Filtered Trial for Amlodipine Non-responder.
Phase of Trial: Phase III
Latest Information Update: 12 Dec 2013
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 14 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 14 Oct 2008 Actual patient number (531) added as reported by ClinicalTrials.gov.